Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1080963
rs1080963
0.010 GeneticVariation BEFREE Depressive symptoms, but not rs1080963, were also significantly associated with higher fasting insulin, insulin area under the curve and insulin resistance (Homeostasis Model Assessment, Homeostasis Model Assessment-2); rs1080963, but not depressive symptoms, was significantly associated with higher fasting glucose and lower Corrected Insulin Response. 30089436

2018

dbSNP: rs112025902
rs112025902
0.010 GeneticVariation BEFREE Our findings provide evidence that rs701848, rs2735343 and rs112025902 polymorphisms in the PTEN gene may be correlated with the risk of depression and depressive symptoms in the Chinese population. 27677222

2016

dbSNP: rs11265263
rs11265263
0.010 GeneticVariation BEFREE Less common recessive genotypes of two single nucleotide polymorphisms in the CRP gene (rs1800947 and rs11265263) were associated with significantly higher mortality risk (p < 0.006), higher CRP levels (p = 0.029, p = 0.006) and increased depressive symptoms in the PHQ-9 (p = 0.005, p = 0.003). 29627531

2018

dbSNP: rs138191010
rs138191010
0.010 GeneticVariation BEFREE A variant located on chromosome 7 was found to be associated with depressive symptoms at age 13 in ALSPAC (rs138191010: β = 0.142, p = 2.51 × 10<sup>-8</sup>), although this was not replicated. 28859627

2017

dbSNP: rs1475157
rs1475157
0.010 GeneticVariation BEFREE i) GG homozygotes (rs1475157-NRN1) showed higher scores on BSI depressive dimension and on total scores compared to A carriers (corrected p-values: 0.0004 and 0.0003, respectively). ii) a linear trend was detected between GG genotype of rs1475157 and a worse cognitive performance in WCST total correct responses (uncorrected p-value: 0.029). iii) Interaction between rs1475157-NRN1 and Val66Met-BDNF was found to modulate depressive symptoms (p=0.001, significant after correction). 28107668

2017

dbSNP: rs7582472
rs7582472
0.010 GeneticVariation BEFREE An association between symptoms of depression and rs7582472 (near to MGAT5 and NCKAP5) was replicated in two independent samples, but other replication findings were less consistent. 22628180

2012

dbSNP: rs1045642
rs1045642
0.010 GeneticVariation BEFREE This study suggests that C3435T polymorphisms in the ABCB1 gene are strongly associated with a predisposition to depression development, the severity of depressive symptoms and the effectiveness of therapy with using different groups of antidepressant agents. 26664259

2015

dbSNP: rs1202184
rs1202184
0.010 GeneticVariation BEFREE The ABCB1 genotypes of rs1922242 (P=0.0028) and rs1202184 (P=0.0021) showed significant association with the severity of depressive symptoms as assessed by the Hamilton Rating Scale for Depression adjusted with Hamilton Rating Scale for Anxiety. 20859246

2011

dbSNP: rs1922242
rs1922242
0.010 GeneticVariation BEFREE The ABCB1 genotypes of rs1922242 (P=0.0028) and rs1202184 (P=0.0021) showed significant association with the severity of depressive symptoms as assessed by the Hamilton Rating Scale for Depression adjusted with Hamilton Rating Scale for Anxiety. 20859246

2011

dbSNP: rs11046205
rs11046205
0.010 GeneticVariation BEFREE There was also a significant association between a different ABCC9 gene variant (rs11046205) and depressive symptoms. 23780892

2013

dbSNP: rs776943620
rs776943620
ACE
0.010 GeneticVariation BEFREE The low activity variants of the 5-HTT-linked polymorphic region in the serotonin transporter gene and the Met-allele of a single nucleotide polymorphism (Val66Met) in the gene encoding brain derived neurotrophic factor were independently associated with the presence of stressful life events prior to onset of depression, also when corrected for the effect of age, gender, marital status, personality disorder, neuroticism, and severity of depressive symptoms at the time of interview. 19339052

2009

dbSNP: rs699
rs699
AGT
0.010 GeneticVariation BEFREE Angiotensinogen M235T polymorphism and symptoms of depression in a population-based study and a family-based study. 18628677

2008

dbSNP: rs1800497
rs1800497
0.010 GeneticVariation BEFREE To examine the potential moderating role of DRD2 polymorphism (rs1800497) in the association between stressful life events and depressive symptoms among young adults. 17585060

2007

dbSNP: rs165599
rs165599
0.010 GeneticVariation BEFREE The rs165599 SNP, which has previously been associated with response of depressive symptoms to treatment in patients with MDD, did not impact baseline pain in either gender. 20627703

2010

dbSNP: rs749437638
rs749437638
0.010 GeneticVariation BEFREE After correcting for Bonferroni multiple tests, we found associations between the MAOA c.1460C>T (SNP 1137070), COMT c.472G>A (SNP 4680), MTHFR c.677C>T (SNP 1801133) and ESR1 454(-351) A>G (SNP 9340799) polymorphisms to mild and moderate depressive symptoms in menopausal women. 26620113

2016

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE There was a significant interaction between C-reactive protein (CRP) and the BDNF Val66met polymorphism in predicting cognitive depressive symptoms (p=.004), such that higher CRP was related to more cognitive depressive symptoms among Met allele carriers, but not among Val/Val homozygotes. 26967918

2016

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE The current study examined the effects of val66met, 5-HTTLPR, and family environment quality on youth depressive symptoms in adolescence and young adulthood in a longitudinal sample oversampled for maternal depression history. 25347540

2014

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE Eighty-two healthy adolescent girls were genotyped for the BDNF val66met polymorphism, and their depressive symptoms and physical activity were assessed using questionnaires. 20230085

2010

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE The objective was to investigate if high cadence cycling altered non-motor cognition and depression symptoms in individuals with Parkinson's disease (PD) and whether exercise responses were influenced by brain-derived neurotrophic factor (BDNF) Val66Met polymorphism. 31197095

2019

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE Furthermore, the BDNF Val66Met polymorphism is a significant factor influencing the severity of anxiety/depression symptoms in schizophrenic patients. 23532065

2013

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE In addition, BDNF Val66Met and 5-HTTLPR polymorphisms seemed to moderate the effect of CSA on adult depressive symptoms. 19215635

2009

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE The present study has provided the first examination of whether working memory capacity, the BDNF Val66Met polymorphism, and their interaction predict changes in symptoms of depression during the transition to university. 24920443

2015

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE The BDNF val66met polymorphism was independently associated with prevalent PSD, but not with persistent and incident PSD nor with depressive symptoms severity. 23399480

2013

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE Among Aβ+ women, ε4 carriers reported greater anxiety symptoms than non-ε4 carriers (d = 0.83), and female BDNF rs6265 Val66 Met allele carriers reported greater depressive symptoms (d = 0.29). 27742526

2016

dbSNP: rs6265
rs6265
0.100 GeneticVariation BEFREE Results indicated the BDNF Val66Met polymorphism significantly moderated the influence of maternal warmth-reasoning, but not harshness-hostility, on youth depressive symptoms. 26510938

2016